Меню
Идёт набор NCT06582693

Refer2Quit: Evaluating a Proactive, Tailored, Population Health Approach for Tobacco Treatment for Household Smokers Through a Pediatric Care Network

Без фазы С лечением Smoking Smoking Cessation Second Hand Tobacco Smoke

Ориентир для пациента и семьи

Простыми словами

Автоматическая сводка по структурированным данным реестра. Она помогает сориентироваться, но не заменяет официальный протокол или оценку врача.

Что изучают
В протоколе указаны: Refer2Quit.
Кому может быть актуально
Состояния в реестре: Smoking, Smoking Cessation, Second Hand Tobacco Smoke. Базовые параметры: от 18 лет · Все.
Что важно проверить
Возраст, диагноз и пол — только базовые ориентиры. Предыдущее лечение, анализы и другие обязательные условия указаны ниже в критериях участия.
Где проводится
США
Следующий шаг
Сохраните исследование, покажите его лечащему врачу и уточните актуальный статус у исследовательского центра. Расходы, документы и поездка →

Обзор

The goal of this clinical trial is to compare the reach and effectiveness of the Refer2Quit intervention for increasing tobacco use treatment and quit rates among household members who smoke versus a treatment as usual group. This clinical trial also aims to study household member and pediatric patient characteristics that are associated with reach and effectiveness of Refer2Quit.

Подробное описание

This study aims to evaluate a proactive and population health-based approach that leverages a clinical decision support (CDS) system embedded in the electronic health record (EHR) to identify household members who smoke but did not complete the smoking survey at the visit, and remotely engage them in tobacco use treatment.

Participants will be recruited through up to 32 outpatient primary care practice from the Children's Hospital of Philadelphia's (CHOP) Pediatric Research Consortium (PeRC). Potential participants will be identified from the cohort of referrals for tobacco cessation treatment. Randomization of adult participants into either the intervention or control group will occur after the participants have consented to partake in the study and completed enrollment. The investigators will deploy a remote recruitment strategy (via phone and/or text) to outreach to eligible adult participants to maximize recruitment efforts.

After the initial referral of the household member who smokes, a study team member will reach out to them, explain the reason they are being contacted and confirm their smoking status and age. All participants will complete the enrollment step with data collection including: adult participant demographics, nicotine dependence and quitting motivation.

Only the intervention arm will receive the opportunity to be automatically connected by the study team to four evidence-based tobacco treatment options: varenicline, nicotine replacement therapy (NRT), quitline, and/or smokefreeTXT. Adult intervention arm participants will also receive brief motivational counseling by the study team.

Adult control arm participants will receive treatment as usual which consistent of a handout of evidence tobacco treatment resources which the adult participant must connect with on their own

Enrolled adult participants in both the intervention and control arms will be followed-up via surveys at approximately 1 and 6-month time intervals. Adult participants who self-report 7-day abstinence at the 1 and 6-month surveys will be asked to confirm smoking cessation through carbon monoxide testing.

Вмешательства

  • Другое Refer2Quit
    The Refer2Quit intervention consists of automatic connection to the adult participant's choice of any or all of four evidence-based tobacco treatment options (varenicline, NRT, quitline, and/or smokefreeTXT), as well as motivational counseling provided by the study team. Supportive and motivational text messaging is also included in the intervention to connect or reconnect adult participants to treatments as needed. Text messaging and support would also focus on supporting appropriate use of NRT

Первичные конечные точки

  • The proportion of adult participants who engage in any evidence-based tobacco use treatments [Срок оценки: Baseline, 1 and 6 months]
  • Combustible tobacco quit rate at 1 and 6 months [Срок оценки: 1 and 6 months]

Критерии участия

Adult Intervention Subject Inclusion Criteria

  • Males or females ages ≥18 years in age
  • Self-identify as a current combustible tobacco user
  • Have a valid cell phone number

Child Intervention Subject Inclusion Criteria

  • Must be a CHOP patient

Adult Intervention Subject Exclusion Criteria

  • <18 years in age.
  • Indicates no combustible tobacco smoking

Child Intervention Subject Exclusion Criteria

  • Not a CHOP patient

Adult Control Subject Inclusion Criteria

  • Males or females ages ≥18 years in age
  • Self-identify as a current combustible tobacco user
  • Have a valid cell phone number

Child Control Subject Inclusion Criteria

  • Must be a CHOP patient

Adult Control Subject Exclusion Criteria

  • <18 years in age.
  • Indicates no combustible tobacco smoking

Child Control Subject Exclusion Criteria

  • Not a CHOP patient

Критерии приведены из реестра в оригинале (на английском). Окончательную оценку соответствия проводит исследовательский центр.

Здоровые добровольцы: Нет

Дизайн исследования

Распределение
Рандомизированное
Модель
Параллельные группы
Маскирование
Простое слепое
Основная цель
Профилактика

Центры проведения

США · 1 центр
  • Children's Hospital of Philadelphia — Philadelphia

Идентификаторы

NCT: NCT06582693 · 23-021075 · 1R37CA282153-01

Первоисточники (государственные реестры)

Открыть это исследование на ClinicalTrials.gov ↗